Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tanja Hinrichsen"'
Autor:
Barbara Dockhorn-Dworniczak, Juliane K. Dworniczak, Bernd Dworniczak, Tanja Hinrichsen, Oliver Wachter
Publikováno v:
LaboratoriumsMedizin. 40:313-322
The term liquid biopsy comprises methods of blood-based analysis of nucleic acids, which are increasingly under discussion in oncology and personalized medicine, and are already applied in individual cases. The analysis of tumor markers, which in cer
Autor:
G Walter, Marion Subklewe, Tanja Hinrichsen, Karsten Spiekermann, Tobias Herold, V Groiß, Klaus H. Metzeler, Irmela Jeremias, Maja Rothenberg, Sebastian Tiedt, Stefan Fröhling, Michaela Grunert, O Wachter, Michela Carlet, H-G Klein, Stephanie Schneider, Nadine Sandhöfer, Alyssa B. Dufour, Wolfgang Hiddemann
Publikováno v:
Leukemia 29, 828-838 (2015)
In acute myeloid leukemia (AML), several signaling pathways such as the phosphatidylinositol-3-kinase/AKT and the mammalian target of rapamycin (PI3K/AKT/mTOR) pathway are deregulated and constitutively activated as a consequence of genetic and cytog
Autor:
Leticia Quintanilla-Martinez, Peter Klapthor, Irina Bonzheim, Falko Fend, Tanja Hinrichsen, Barbara Mankel, Oliver Wachter, Janine Schmidt
Publikováno v:
Blood. 125:2309-2311
To the editor: The understanding of the genetic basis of the myeloproliferative neoplasms has increased tremendously in the last few years.[1][1] In essential thrombocythemia (ET), 50% to 65% of the patients carry the JAK2 V617F mutation, whereas onl
Publikováno v:
Transfusion Medicine and Hemotherapy. 40:196-206
With the introduction of the next generation sequencing (NGS) technologies, remarkable new diagnostic applications have been established in daily routine. Implementation of NGS is challenging in clinical diagnostics, but definite advantages and new d
Autor:
Monika Bühl-Göpfert, Tanja Hinrichsen
Publikováno v:
LaboratoriumsMedizin. 33:271-281
Autor:
Konstanze Döhner, Eric Yung, Bob Argiropoulos, Tanja Hinrichsen, Cornelia Rudolph, Axel Schambach, Arnold Ganser, Florian Kuchenbauer, Brigitte Schlegelberger, Hartmut Döhner, Jessica Piper, Stephen Fung, Richard F. Schlenk, Christopher Baum, Michael Heuser, R. Keith Humphries
Publikováno v:
Blood. 110:1639-1647
Overexpression of wild-type MN1 is a negative prognostic factor in patients with acute myeloid leukemia (AML) with normal cytogenetics. We evaluated whether MN1 plays a functional role in leukemogenesis. We demonstrate using retroviral gene transfer
Autor:
Sabine Hertz, Doris Steinemann, Anja Weigmann, Sarah Tauscher, Brigitte Schlegelberger, Peter Lichter, Thomas Becker, Tanja Hinrichsen, Jacobus Flik, B. Wiese, Peer Flemming, Ludwig Wilkens, Hans Kreipe, Britta Skawran, Luzie U. Wingen, Marcel Tauscher
Publikováno v:
Clinical Gastroenterology and Hepatology. 4:1283-1291
To gain more information about the molecular mechanisms leading to dedifferentiation of hepatocellular adenoma (HCA) and hepatocellular carcinoma (HCC), high-resolution array-based comparative genomic hybridization (array-CGH) was performed on 24 cas
Publikováno v:
Blood. 128:5604-5604
A 75-year-old patient with slowly increasing polyneuropathy (PNP) (sensitive PNP, WHO°2), pre-existing for 6 months, in conjunction with a monoclonal gammopathy (IgG/kappa) is presented. Significant pre-existing conditions (for example, diabetes) do
Autor:
Sonja Beicht, Elke Kaminsky, Hanns-Georg Klein, Lutz T. Weber, Sabine Rath, Gertrud Strobl-Wildemann, Martin Alberer, Oliver Wachter, Tanja Hinrichsen, Julia Hoefele
Publikováno v:
Gene. 526(2)
Alport syndrome (ATS) is a progressive hereditary nephropathy characterized by hematuria and/or proteinuria with structural defects of the glomerular basement membrane. It can be associated with extrarenal manifestations (high-tone sensorineural hear
Autor:
Volker Groiß, Sebastian Tiedt, Nadine Sandhöfer, Karsten Spiekermann, Evelyn Zellmeier, Tanja Hinrichsen, Klaus H. Metzeler, Irmela Jeremias, Wolfgang Hiddemann, Oliver Wachter, Hanns-Georg Klein
Publikováno v:
Blood. 122:818-818
Background Despite the recent advances and better understanding of the biology of acute myeloid leukemia (AML), only little improvement was achieved in treatment and cure rates. One of the key signaling pathways known to be frequently deregulated in